86 related articles for article (PubMed ID: 15247706)
1. Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma.
Yamasaki M; Nomura T; Mimata H; Nomura Y
J Urol; 2004 Aug; 172(2):475-6. PubMed ID: 15247706
[No Abstract] [Full Text] [Related]
2. Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma.
Kwak C; Park YH; Kim IY; Moon KC; Ku JH
J Urol; 2007 Sep; 178(3 Pt 1):1062-7. PubMed ID: 17644140
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of bone morphogenetic protein 2 in heterotopic ossification in metastatic lesion from urothelial carcinoma of bladder.
Komai Y; Morimoto S; Saito K; Urushibara M; Sakai K; Ikeda S
Int J Urol; 2006 Aug; 13(8):1126-8. PubMed ID: 16903944
[TBL] [Abstract][Full Text] [Related]
4. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
5. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
[No Abstract] [Full Text] [Related]
7. Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism.
Kypson AP; Morphew E; Jones R; Gottfried MR; Seigler HF
J Surg Oncol; 2003 Feb; 82(2):132-6; disccussion 137. PubMed ID: 12561070
[TBL] [Abstract][Full Text] [Related]
8. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
[TBL] [Abstract][Full Text] [Related]
9. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
[TBL] [Abstract][Full Text] [Related]
10. Sarcomatoid renal cell carcinoma with osteosarcomatous differentiation--a case report.
Handoo A; Pai RR; Rao VS; Sanjeeva VB
Indian J Pathol Microbiol; 2004 Oct; 47(4):528-9. PubMed ID: 16295385
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic proteins in human lung carcinomas.
Langenfeld EM; Bojnowski J; Perone J; Langenfeld J
Ann Thorac Surg; 2005 Sep; 80(3):1028-32. PubMed ID: 16122479
[TBL] [Abstract][Full Text] [Related]
12. A member of the transforming growth factor-beta receptor family from Echinococcus multilocularis is activated by human bone morphogenetic protein 2.
Zavala-Góngora R; Kroner A; Bernthaler P; Knaus P; Brehm K
Mol Biochem Parasitol; 2006 Apr; 146(2):265-71. PubMed ID: 16434111
[No Abstract] [Full Text] [Related]
13. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
14. A novel entity: low-grade mucinous tubular renal carcinoma.
Ferlicot S; Lupo A; Lazure T; Bedossa P; Vieillefond A
Histopathology; 2005 Aug; 47(2):218-9. PubMed ID: 16045786
[No Abstract] [Full Text] [Related]
15. Characterization of primary renal carcinoma cultures.
Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
[TBL] [Abstract][Full Text] [Related]
17. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literature.
Kuhn E; De Anda J; Manoni S; Netto G; Rosai J
Am J Surg Pathol; 2006 Nov; 30(11):1372-81. PubMed ID: 17063076
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma].
Tan WL; Xiong L; Zheng SB; Yu ZC; Qi H; Du YJ; Wu P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1316-8. PubMed ID: 16982445
[TBL] [Abstract][Full Text] [Related]
20. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
